Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 15 Squamous Cell Carcinoma of Head and Neck 11 Small Cell Lung Carcinoma 9 Lung Neoplasms 9 Oropharyngeal Neoplasms 7 Mouth Neoplasms 6 Laryngeal Neoplasms 6 Carcinoma 6 Uterine Cervical Neoplasms 5 Urinary Bladder Neoplasms 5 Stomach Neoplasms 4 Hypopharyngeal Neoplasms 4 Breast Neoplasms 4 Adenocarcinoma of Lung 4 Pancreatic Neoplasms 3 Nasopharyngeal Carcinoma 3 Brain Neoplasms 3 Vulvar Neoplasms 2 Salivary Gland Neoplasms 2 Recurrence 2 Paranasal Sinus Neoplasms 2 Ovarian Neoplasms 2 Medulloblastoma 2 Lymphoid Interstitial Pneumonia 2 Liver Neoplasms 2 Head and Neck Neoplasms 2 Fallopian Tube Neoplasms 2 Cholangiocarcinoma 2 Anus Neoplasms 2 Urethral Neoplasms 1

Interventions

Fluorouracil 6 Cisplatin 4 Radiotherapy, Intensity-Modulated 3 Radiotherapy 3 Magnetic Resonance Spectroscopy 3 Capecitabine 3 dehydroftorafur 2 Specimen Handling 2 Mitomycin 2 Cetuximab 2 toripalimab 1 rocakinogene sifuplasmid 1 pembrolizumab 1 durvalumab 1 atezolizumab 1 Vaccines 1 VGX-3100 1 Taxes 1 Radiosurgery 1 Radiation 1 Platinum 1 Paclitaxel 1 Nivolumab 1 Mitozytrex 1 Mitomycins 1 MEDI0457 1 Ipilimumab 1 Immunoglobulin G 1 Fluorodeoxyglucose F18 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Anal Canal Carcinoma × Platinum × Clear all

NCT02560298 2023-06-22

InterAACT

Eastern Cooperative Oncology Group

Phase 2 Unknown

Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡